News Focus
News Focus
Followers 15
Posts 1612
Boards Moderated 1
Alias Born 09/07/2010

Re: jbog post# 13910

Friday, 06/19/2015 11:54:14 AM

Friday, June 19, 2015 11:54:14 AM

Post# of 20689
As I recall, MNTA's revenues dropped once its Enoxaparin share went from 45% of profits to the straight royalty of 10-12% on Sandoz' net sales. So, unless that was all due to the price drop caused by Watson's entry, this should represent a revenue improvement.

“It is possible to be a normal decent person and yet to be fully alive.” - George Orwell